Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGPOR.L Share News (GPOR)

  • There is currently no data for GPOR

Friday broker round-up UPDATE

Fri, 20th Dec 2013 09:12
African Barrick Gold: Canaccord Genuity takes target price from 125p to 195p upgrading from hold to buy.Ashmore Group: UBS raises target price from 390p to 430p upgrading from neutral to buy.BAE Systems: JP Morgan cuts target price from 380p to 355p and maintains its underweight rating. UBS lowers target price from 490p to 475p, while retaining its buy recommendation.Carnival: UBS raises target price from 2100p to 2500p upgrading from neutral to buy.Centamin: Canaccord Genuity ups target price from 38p to 60p and upgrades from hold to a speculative buy.Clean Air Power: Cantor Fitzgerald lowers target price of 19p to 15p and retains its buy recommendation.CRH: Liberum Capital increases target price from 1150p to 1630p and keeps a hold recommendation.Darty: JP Morgan ups target price from 40p to 85p, while leaving its underweight unchanged.Euromoney: Westhouse Securities downgrades from neutral to sell with a target price of 1110p.Great Portland: Numis raises target price from 595p to 650p staying with its add rating.Heritage Oil: UBS moves target price from 200p to 220p and maintains a buy recommendation.Kenmare Resources: Canaccord Genuity shifts target price from 25p to 24p maintaining a buy recommendation.Lloyds Banking Group: Canaccord Genuity takes target price from 35p to 70p and retains a hold recommendation.Marks & Spencer: Cantor Fitzgerald lowers target price from 445p to 425p retaining its sell recommendation.Minera IRL: Canaccord Genuity cuts target price from 40p to 22p, while leaving its buy recommendation unaltered.Pan African: Canaccord Genuity moves target price from 16p to 18p and reiterates a buy recommendation.Polymetal: Canaccord Genuity reduces target price from 850p to 580p, while its buy recommendation remains unchanged.Randgold Resources: Canaccord Genuity reduces target price from 5700p to 4100p and downgrades from buy to hold.Serco Group: UBS ups target price from 480p to 505p and reiterates a buy recommendation. JP Morgan reduces target price from 544p to 523p and stays with its overweight rating.Synergy Energy: N+1 Singer cuts target price from 1220p to 1200p downgrading from buy to hold.

Related News

LONDON BRIEFING: Babcock raises annual dividend as revenue grows
12 mins ago

LONDON BRIEFING: Babcock raises annual dividend as revenue grows

(Alliance News) - Stocks were called higher on Monday after the US and Iran, mediators said, agreed to set up communications lines to keep the vital S...

European stocks tick lower as mining losses weigh
2 days ago

European stocks tick lower as mining losses weigh

* Investor sentiment hurt as U.S.-Iran talks called off

France mobilises €13 billion for tech sovereignty funding push
2 days ago

France mobilises €13 billion for tech sovereignty funding push

PARIS, June 19 (Reuters) - France ​has ⁠mobilised €13 billion ($14.89 billion) in ​additional institutional investor funding under the third phase of ...

GPOR.L News

Great Portland Estates upbeat after quarter of lettings
26 Jan 2017

Great Portland Estates upbeat after quarter of lettings

(ShareCast News) - Great Portland Estates published its trading update for the quarter to 31 December on Thursday, with 16 new lettings totalling 86,6...

Sector movers: REITS, electricity stocks drop
19 Jan 2017

Sector movers: REITS, electricity stocks drop

(ShareCast News) - Tobacco stocks rose to the top of the leaderboard after analysts at Citi sung the praises of British American. In a research note s...

Exane upgrades British Land on valuation but remains cautious on UK property
5 Jan 2017

Exane upgrades British Land on valuation but remains cautious on UK property

(ShareCast News) - Exane BNP Paribas upgraded British Land to 'neutral' from 'underperform' and lifted the price target 6% to 700p on valuation ground...

Tuesday broker round-up
13 Dec 2016

Tuesday broker round-up

(ShareCast News) - British Land: Barclays reiterates overweight with a target price of 740p. GlaxoSmithKline: UBS reiterates neutral, 1600p target. R...